Cancer Research · 2011 · 57 citations · 12 references
MedicineMolecular BiologyOncologyCarcinogenesisMolecular OncologyOncogenesCancer ProgressionCellular SenescenceOncogene ActivationOncogene OverexpressionTranscription Factor OncogenesTumor Suppressor GenesCancer Cell SenescenceCell SenescenceCyclin-dependent Kinase InhibitorsHypoxic MicroenvironmentOncogenic TransformationP16ink4a PathwayP16ink4a RegulationTumor Microenvironment Hypoxia
Many cancers overexpress ATF4, a stress-induced transcription factor that promotes cell survival under hypoxic conditions and other stresses of the tumor microenvironment, but the potential contributions of ATF4 to oncogenesis itself have been little explored. Here, we report that ATF4 promotes oncogene-induced neoplastic transformation by suppressing the expression of cellular senescence-associated genes. Strikingly, primary embryo fibroblasts from ATF4-deficient mice were resistant to transformation by coexpression of H-ras(V12) and SV40 large T antigen. In wild-type cells these oncogenes induced expression of the murine Atf4 gene along with the cyclin-dependent kinase inhibitor Cdkn2a, which encodes the cell senescence-associated proteins p16INK4 and p19ARF. Elevated levels of ATF4 were sufficient to suppress expression of these proteins and drive oncogenic transformation. Conversely, genetic ablation of ATF4 led to constitutive expression of p16INK4a and p19ARF, triggering cellular senescence. Our findings define a central function for ATF4 in promoting oncogenic transformation by suppressing a central pathway of cellular senescence.
12
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Takehiko Kamijo, Frédérique Zindy, Martine F. Roussel et al. · Cell · 1997 · 1.6K citations · Full text
The KEGG databases at GenomeNet
Minoru Kanehisa · Nucleic Acids Research · 2002 · 1.5K citations · Full text
Senescence in premalignant tumours
Manuel Collado, Jesús Gil, Alejo Efeyan et al. · Nature · 2005 · 1.5K citations
Medicine, Cancer Biology, Oncology +12